Important progress in product development – simultaneous staining in the same section, with high degree of detail

Lumito is developing a novel method for high-contrast imaging without background signal. The first application is developed for tissue diagnostics and digital pathology. In order to visualize cells containing Her2, which is a common marker in breast cancer diagnostics, Lumito is now presenting new images of breast tissues stained with the Company's Her2-UCNP reagent. Lumito's […]

The alpha prototype of the instrument delivered to Lumito according to plan

Lumito’s development partner TTP has delivered the alpha prototype of what will be Lumito’s first product. After delivery, the instrument has successfully undergone internal acceptance testing. The ongoing development phase of Lumito’s first product includes the development of an alpha prototype, with essential functionality implemented (“work like”), and thereafter a beta prototype, with complete implementation […]

Lumito presents results from the successful proof of concept phase

As previously disclosed the results from the first histological assay (Link to supporting material) (https://www.lumito.se/en/technology/concept-phase/) are very promising and corroborate a rapid development and release of Lumito’s unique products to the market. Lumito performed the assay together with the company’s development partner The Technology Partnership (TTP) and the external research laboratory BioIVT using proof of concept prototypes; tissue staining kit and instrument for […]